20
InSitu Biologics, Inc. files Form D
Company raise update · Raising · Offering $3.4M · Sold $1.3M · OAKDALE, MN · filed 2026-10-14
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
| Bill Taylor | Executive Officer |
| Robert Wilson | Director |
| Greg Van Guilder | Director |
| Daniel Halpern | Executive Officer, Director |
| Sandi Klemann | Executive Officer |
| Ivan Shaw | Director |
Signed by Daniel Halpern, Chief Executive Officer.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.